Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||
Cost of Revenue | ||||||||||
Gross Profit | ||||||||||
Gross Profit Margin (%) | ||||||||||
R&D Expense | ||||||||||
SG&A Expense | ||||||||||
Total Operating Expenses | ||||||||||
Operating Income or Loss | ||||||||||
Operating Margin (%) | ||||||||||
Interest Expense | ||||||||||
Total Other Income/Expenses | ||||||||||
Income Before Tax | ||||||||||
Income Tax Expense | ||||||||||
Income from Continuing Ops. | ||||||||||
Net Income | ||||||||||
Net Profit Margin (%) | ||||||||||
Net Income Available to Common Shareholders | ||||||||||
Basic EPS | ||||||||||
Diluted EPS | ||||||||||
Basic Average Shares | ||||||||||
Diluted Average Shares |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||
Cost of Revenue | |||||||||||||
Gross Profit | |||||||||||||
Gross Profit Margin (%) | |||||||||||||
R&D Expense | |||||||||||||
SG&A Expense | |||||||||||||
Total Operating Expenses | |||||||||||||
Operating Income or Loss | |||||||||||||
Operating Margin (%) | |||||||||||||
Interest Expense | |||||||||||||
Total Other Income/Expenses | |||||||||||||
Income Before Tax | |||||||||||||
Income Tax Expense | |||||||||||||
Income from Continuing Ops. | |||||||||||||
Net Income | |||||||||||||
Net Profit Margin (%) | |||||||||||||
Net Income Available to Common Shareholders | |||||||||||||
Basic EPS | |||||||||||||
Diluted EPS | |||||||||||||
Basic Average Shares | |||||||||||||
Diluted Average Shares |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||
Cash & Cash Equivalents | ||||||||||
Marketable Securities | ||||||||||
Receivables | ||||||||||
Inventories | ||||||||||
Other Current Assets | ||||||||||
Total Current Assets | ||||||||||
Non-Current Assets | ||||||||||
Marketable Securities | ||||||||||
PPE Net | ||||||||||
Intangibles inc. Goodwill | ||||||||||
Other Non-Current Assets | ||||||||||
Total Non-Current Assets | ||||||||||
Total Assets | ||||||||||
Current Liabilities | ||||||||||
Accounts Payable | ||||||||||
Deferred Revenues | ||||||||||
Debt, Current | ||||||||||
Accrued Liabilities | ||||||||||
Other Current Liabilities | ||||||||||
Total Current Liabilities | ||||||||||
Non-Current Liabilities | ||||||||||
Deferred Revenues | ||||||||||
Debt, Non-Current | ||||||||||
Other Non-Current Liabilities | ||||||||||
Total Non-Current Liabilities | ||||||||||
Total Liabilities | ||||||||||
Shareholders' Equity | ||||||||||
Common Stock | ||||||||||
Additional Paid-In Capital | ||||||||||
Retained Earnings | ||||||||||
Other Shareholders' Equity | ||||||||||
Total Shareholders' Equity | ||||||||||
Total Liabilities & Shareholders' Equity |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||
Cash & Cash Equivalents | |||||||||||||
Marketable Securities | |||||||||||||
Receivables | |||||||||||||
Inventories | |||||||||||||
Other Current Assets | |||||||||||||
Total Current Assets | |||||||||||||
Non-Current Assets | |||||||||||||
Marketable Securities | |||||||||||||
PPE Net | |||||||||||||
Intangibles inc. Goodwill | |||||||||||||
Other Non-Current Assets | |||||||||||||
Total Non-Current Assets | |||||||||||||
Total Assets | |||||||||||||
Current Liabilities | |||||||||||||
Accounts Payable | |||||||||||||
Deferred Revenues | |||||||||||||
Debt, Current | |||||||||||||
Accrued Liabilities | |||||||||||||
Other Current Liabilities | |||||||||||||
Total Current Liabilities | |||||||||||||
Non-Current Liabilities | |||||||||||||
Deferred Revenues | |||||||||||||
Debt, Non-Current | |||||||||||||
Other Non-Current Liabilities | |||||||||||||
Total Non-Current Liabilities | |||||||||||||
Total Liabilities | |||||||||||||
Shareholders' Equity | |||||||||||||
Common Stock | |||||||||||||
Additional Paid-In Capital | |||||||||||||
Retained Earnings | |||||||||||||
Other Shareholders' Equity | |||||||||||||
Total Shareholders' Equity | |||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||
Net Income | ||||||||||
Depreciation & Amortization | ||||||||||
Deferred Income Taxes | ||||||||||
Stock Based Compensation | ||||||||||
Accounts Receivable | ||||||||||
Inventory | ||||||||||
Accounts Payable | ||||||||||
Deferred Revenue | ||||||||||
Other Non-Cash | ||||||||||
Operating Cash Flow | ||||||||||
Cash Flows from Investing Activities | ||||||||||
PPE Investments | ||||||||||
Net Acquisitions | ||||||||||
Purchase of Investments | ||||||||||
Sale of Investments | ||||||||||
Other Investing Activity | ||||||||||
Investing Cash Flow | ||||||||||
Cash Flows from Financing Activities | ||||||||||
Debt Issued | ||||||||||
Proceeds from Debt Repayment | ||||||||||
Debt Repayment | ||||||||||
Proceeds from Sale of Equity | ||||||||||
Equity Repurchased | ||||||||||
Dividend Paid | ||||||||||
Other Financing Activity | ||||||||||
Financing Cash Flow | ||||||||||
Cash Position | ||||||||||
Beginning Cash Position | ||||||||||
End Cash Position | ||||||||||
Change in Cash | ||||||||||
Free Cash Flow | ||||||||||
Operating Cash Flow | ||||||||||
Capital Expenditure | ||||||||||
Free Cash Flow |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||
Net Income | |||||||||||||
Depreciation & Amortization | |||||||||||||
Deferred Income Taxes | |||||||||||||
Stock Based Compensation | |||||||||||||
Accounts Receivable | |||||||||||||
Inventory | |||||||||||||
Accounts Payable | |||||||||||||
Deferred Revenue | |||||||||||||
Other Non-Cash | |||||||||||||
Operating Cash Flow | |||||||||||||
Cash Flows from Investing Activities | |||||||||||||
PPE Investments | |||||||||||||
Net Acquisitions | |||||||||||||
Purchase of Investments | |||||||||||||
Sale of Investments | |||||||||||||
Other Investing Activity | |||||||||||||
Investing Cash Flow | |||||||||||||
Cash Flows from Financing Activities | |||||||||||||
Debt Issued | |||||||||||||
Proceeds from Debt Repayment | |||||||||||||
Debt Repayment | |||||||||||||
Proceeds from Sale of Equity | |||||||||||||
Equity Repurchased | |||||||||||||
Dividend Paid | |||||||||||||
Other Financing Activity | |||||||||||||
Financing Cash Flow | |||||||||||||
Cash Position | |||||||||||||
Beginning Cash Position | |||||||||||||
End Cash Position | |||||||||||||
Change in Cash | |||||||||||||
Free Cash Flow | |||||||||||||
Operating Cash Flow | |||||||||||||
Capital Expenditure | |||||||||||||
Free Cash Flow |